 |
PDBsum entry 3pe1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
3pe1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
Unprecedented selectivity and structural determinants of a new class of protein kinase ck2 inhibitors in clinical trials for the treatment of cancer.
|
|
|
Authors
|
|
R.Battistutta,
G.Cozza,
F.Pierre,
E.Papinutto,
G.Lolli,
S.Sarno,
S.E.O'Brien,
A.Siddiqui-Jain,
M.Haddach,
K.Anderes,
D.M.Ryckman,
F.Meggio,
L.A.Pinna.
|
|
|
Ref.
|
|
Biochemistry, 2011,
50,
8478-8488.
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
Secondary reference #1
|
|
|
Title
|
|
Quinalizarin as a potent, Selective and cell-Permeable inhibitor of protein kinase ck2.
|
|
|
Authors
|
|
G.Cozza,
M.Mazzorana,
E.Papinutto,
J.Bain,
M.Elliott,
G.Di maira,
A.Gianoncelli,
M.A.Pagano,
S.Sarno,
M.Ruzzene,
R.Battistutta,
F.Meggio,
S.Moro,
G.Zagotto,
L.A.Pinna.
|
|
|
Ref.
|
|
Biochem J, 2009,
421,
387-395.
|
|
|
PubMed id
|
|
|
|
|
|
|
|
|
|
|
|
|
